EGFR and cancer: Predicted targets of the five downregulated miRNAs were enriched for multiple cancer-related pathways, including PI3K–Akt, ErbB, EGFR inhibitor resistance, chemical carcinogenesis, and the “microRNAs in cancer” pathway (Figure 3A).